EKSO · NASDAQ · Information Technology Services

Ekso Bionics (EKSO)

Wearable exoskeletons for rehabilitation, personal mobility, and industrial arm support.

$15.90
At close−1.74 (−9.86%)
No recent trading data

In millions of USD, except per-share figures

In millionsQ2 FY23Jun 2023Q3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026
Revenue555454532432
Cost of revenue222222221211
Gross profit222232321321
756555555467
Research & development111111111111
545444444366
Selling & marketing222222222122
General & administrative323222232234
Other expenses000000000000
Operating income−4−3−3−3−2−3−2−3−4−1−5−6
000001−11100−1
Interest expense000000000000
Other non-operating income00000−110−1001
Income before tax−4−3−3−3−2−2−3−3−3−1−5−7
Net income from continuing operations−4−3−3−3−2−2−3−3−3−1−5−7
Net income−4−3−3−3−2−2−3−3−3−1−5−7
EPS, basic−$4.65−$3.59−$3.34−$2.95−$1.99−$1.53−$2.08−$1.71−$1.24−$0.54−$1.57−$2.04
EPS, diluted−$4.65−$3.59−$3.34−$2.95−$1.99−$1.53−$2.08−$1.71−$1.24−$0.54−$1.57−$2.04
Weighted average shares, basic111111222334
Weighted average shares, diluted111111222334
EBITDA−4−3−2−3−2−2−3−3−2−1−4−6
Depreciation & amortization001000000000
EBIT−4−3−3−3−2−2−3−3−3−1−4−7